The global clinical nutrition market is expected to grow at a CAGR of 8.40% during the forecast period. Some of the major factors driving the growth of the clinical nutrition market include the growing geriatric population, increasing incidence of malnutrition among hospitalized patients and the growing prevalence of communicable and non-communicable chronic diseases such as diabetes and obesity. Further, the growing number of premature births and the rising demand for specialized infant formula are also driving the market growth.

Awareness of personal hygiene and soaring cases COVID-19 propel the demand for hand hygiene solutions, including automatic paper towel dispensers. The market is witnessing high demand from sectors such as healthcare, hospitality, residential, education, corporates, and various government agencies and militaries. The demand for automatic paper towel dispensers from such markets has also grown in countries such as China, Germany, Japan, and India due to the booming commercial real estate, hospitality, corporate, and education markets and a shift in consumer behavior toward personal hygiene in developing countries. The emergence of sensor-based paper towel dispensers will have a positive impact on the market and contribute to its growth over the forecast period.

Currently, Covid-19 has created an opportunity for FMCG companies to launch antimicrobial disinfectants to address changing consumer needs. Also, due to COVID-19, consumers are concerned about hygiene and safe consumption of food products. Earlier, antimicrobial food disinfectants were rarely used in residential and some commercial sectors. Also, cleaning of food products was majorly limited to washing in running or boiled water. However, trends are changing and are expected to change further during the forecast period with respect to more sale of disinfectants due to increase in foodborne illness in different countries.

The report provides market dynamics and trends related to the global cancer vaccines market. In addition, it presents estimations and forecast of the market. The study estimates revenue generated from sales of cancer vaccines; however, it excludes cancer vaccines service revenue. Valuations comprise revenue generated from technologies such as dendritic cells (DC) cancer vaccines, recombinant cancer vaccines, antigen/adjuvant cancer vaccines, and viral vector & DNA cancer vaccines. Furthermore, the report excludes revenue generated from post-sale services of cancer vaccines products.

Hemodialysis catheter is used for exchanging blood to and from hemodialysis device and a patient. The report provides market dynamics and trends related to the global chronic hemodialysis catheter market. In addition, it presents estimations and forecast of the market. The study estimates revenue generated from the sales of chronic hemodialysis catheters; however, it excludes chronic hemodialysis catheter service revenue. The valuations comprise revenue generated from chronic hemodialysis catheter type of tip such as step-tip catheter, split-tip catheter, and symmetric tip catheter. Furthermore, the report excludes revenue generated from postsale services of chronic hemodialysis catheter products.

Disposable gloves are widely used in medical and nonmedical applications to avoid cross-infection between caregivers and patients. Disposable gloves are utilized to avoid accidental contact to harmful infectious sites or areas. Various types of materials have been used in the manufacturing of disposable gloves, namely, natural rubber, nitrile, vinyl, neoprene, and others. This report focuses on disposable gloves used in medical and nonmedical purposes, including food, retail, and industrial for non-medical and examination, forensics, and surgeries in the medical category. The report also covers both powered and non-powdered variants. The report excludes the market for non-disposable gloves that comprise safety/non-disposable/leather gloves. The regional market for North America, Europe, Asia-Pacific, and LAMEA has been studied, with respect to countries analyzed at regional level. The revenue from both local as well as global manufacturers has been considered during the analysis.

Dental insurance is a type of contract that is represented by a policy and covers only the dental health or oral health of a person. Insurers have simplified their product offerings & made them straightforward with selective coverages and provide comparison of multiple dental treatments in terms of protection and premiums for selected coverages. Moreover, dental insurance reimburses several dental costs incurred by the patients and the insurers have been profiting from rise in number of individuals with high income, increased per capita earnings, and surge in working class population. For the purpose of analysis, the report of dental insurance market is segmented the basis of coverage, type, demographics, end user, and region. The highlights the various coverages available in the market, which include dental preferred provider organizations (DPPO), dental health maintenance organizations (DHMO), dental indemnity plans, and others. In addition, it covers various types of insurance offered, including major, basic, and preventive. Furthermore, it provides a detailed description on various demographics such as senior citizens, adults, and minors. The end users include individuals and corporates. An in-depth analysis across North America, Europe, Asia-Pacific, and LAMEA has been included in the study.

DNA damage leads to the incorporation and accumulation of aberrations and defects in the genome, which results in potential mutations. The occurrence of mutations in genes having vital proteins or enzymes leads to the development of cancer. However, the biological system is equipped with an effective repair mechanism capable of repairing the damaged DNA sequences in the cells. DNA damage response (DDR) drugs are used as a therapeutic strategy for augmenting the innate DNA repair mechanism, thereby aiding advanced cancer treatments. The development of DDR drugs potentially harnesses proteins involved in the DDR pathway such as Poly (ADP-ribose) polymerase (PARP), WEE1, Aurora B, ATM kinase, and ATR kinase.

DNA methylation is a heritable epigenetic marker which involves the covalent transfer of a methyl group to the C-5 position of the cytosine ring of DNA by enzymes known as DNA methyltransferases (DNMTs). In humans, DNA methylation occurs primarily at cytosines in any context of the genome. More than 98% of DNA methylation occurs in a CpG dinucleotide context in somatic cells. The current study aims to assess the global DNA methylation market by focusing on evaluating products catering to the aforementioned definition. The current scenario of DNA methylation detection and diagnosis is mainly dominated by several diagnostic majors, such as Illumina, Inc., Thermo Fisher Scientific Inc., Merck Group, and QIAGEN N.V., which offer a wide variety of products ranging from molecular-genetic tests to sequencing instruments for the confirmatory detection and diagnosis of DNA methylation. These products are generally based on technologies, such as polymerase chain reaction (PCR), microarrays, and sequencing, including both traditional and next-generation sequencing. The underlying utility of diagnostic testing for DNA methylation is based on the identification of clinically actionable genetic function, which provide crucial information on diagnosis, prognosis, and theranostics of genetic disorders and thereby facilitates clinical work-up, treatment management, and therapeutic selection.

Drug screening is used to identify prescription drugs and illicit drugs in urine, plasma, and other biological samples. Urine testing is the most commonly used sample type for drug screening. The report provides market dynamics and trends related to the global drug screening laboratory services market. In addition, it presents estimations and forecast of the drug screening services market majorly performed for various workplaces. The study estimates revenue generated from the services offered. The valuations comprise revenue generated from drug laboratory services. However, the report excludes revenues generated by counseling fees of doctors or healthcare providers who suggest various types of drug screening tests.